Clinical Studies

For additional information about Harvard Eye Associates’ clinical trials, please visit ClinicalTrials.gov.

Below is a list of ongoing studies at Harvard Eye Associates:

Cataract Surgery

Sponsor: CORD, LLC
A prospective clinical trial to evaluate the safety and effectiveness of Model SC9 Posterior Chamber Silicone Intraocular lens for primary implantation in the capsular bag of the eye for visual correction of aphakia secondary to removal of aphakia secondary to removal of a cataractous lens in adult patients with or without presbyopia.  The IOL is intended to improve near and intermediate vision as compared to a legally marketed monofocal IOL.

Principal Investigator:  John Hovanesian, MD 
Sub Investigator:  Nicoletta Stefanidis, OD

Sponsor:  Alcon Research, Ltd.
Post Approval Study of the AcrySof® IQ ReSTOR® Toric IOLs

Principal Investigator:  John Hovanesian, MD 

Sponsor: AcuFocus, Inc.
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens.

Principal Investigator:  John Hovanesian, MD 
Website: ic8lensclinicalstudy.com

Sponsor: MDbackline
Mini-monovision with ActiveFocus Implants.  A Study of Patient Satisfaction, Visual Disturbances, and Uncorrected Visual Performance.

Principal Investigator:  John Hovanesian, MD 

Cornea and External Diseases

Sponsor: MDbackline
The Effect of Lifitegrast on Refractive Accuracy and Symptoms in Dry Eye Patients Undergoing Cataract Surgery.

Principal Investigator:  John Hovanesian, MD 

Glaucoma

Sponsor: Aerie Pharmaceuticals, Inc.
A multicenter, open-label study of Rhopressa® (Netarsudil Ophthalmic Solution) 0.02% for the reduction of elevated intraocular pressure in patients with glaucoma or ocular hypertension in a real-world setting.

Principal Investigator:  Savak Teymoorian, M.D. 

 

For additional information on our clinical studies, please contact:

Leslie Lemieux, Clinical Research Coordinator
(949) 900-5248
llemieux@harvardeye.com